Lv5
1560 积分 2023-11-13 加入
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
1天前
已完结
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
1天前
已完结
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
1天前
已完结
Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL
1天前
求助中
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
1天前
已完结
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
1天前
已完结
Inclisiran: a new generation of lipid-lowering siRNA therapeutic
1个月前
已完结
Ebronucimab in Chinese Patients with Hypercholesterolemia---A Randomized Double-Blind Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Ebronucimab
1个月前
已完结
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
2个月前
已完结
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
2个月前
已完结
皖公网安备34019202002308
